AMARIN CORP PLC\UK

Amarin Corp. Plc\uk

Drug Manufacturers - General • Healthcare • Dublin, Ireland • AMRN (NCM)

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom (NASDAQ:AMRN) - Seeking Alpha
Seeking Alpha • Sep 29
Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance
Yahoo Finance • Oct 6
Amarin (NASDAQ: AMRN) shares REDUCE-IT aspirin analysis showing 36% fewer total CV events - Stock Titan
Stock Titan • Nov 9
Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Nasdaq
Nasdaq • Aug 14
Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com
Investing.com • Sep 2

Other Drug Manufacturers - General Companies

View All →
ELI LILLY & Co logo ELI Lilly & Co.
$827.33B market cap
JOHNSON & JOHNSON logo Johnson & Johnson
$500.07B market cap
AbbVie Inc. logo Abbvie Inc.
$406.46B market cap
ASTRAZENECA PLC logo Astrazeneca PLC
$281.04B market cap
NOVARTIS AG logo Novartis AG
$273.20B market cap
Merck & Co., Inc. logo Merck & Co. Inc.
$266.89B market cap

Frequently Asked Questions

Has AMARIN CORP PLC\UK had layoffs?
No layoff events have been recorded for AMARIN CORP PLC\UK in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does AMARIN CORP PLC\UK have?
AMARIN CORP PLC\UK has approximately 275 employees.
What industry is AMARIN CORP PLC\UK in?
AMARIN CORP PLC\UK operates in the Drug Manufacturers - General industry, within the Healthcare sector.
Is AMARIN CORP PLC\UK a publicly traded company?
Yes, AMARIN CORP PLC\UK is publicly traded under the ticker symbol AMRN on the NCM. The company has a market capitalization of approximately $0.28 billion.
Where is AMARIN CORP PLC\UK headquartered?
AMARIN CORP PLC\UK is headquartered in Dublin, Ireland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.